RNS Number : 1137F
NetScientific PLC
10 November 2015
 

NetScientific PLC

("NetScientific" or the "Group")

 

Grant of Options to Director

 

London, UK - 10 November 2015: NetScientific plc (AIM:NSCI), a transatlantic biomedical healthcare group, announces that on 9 November 2015, options over a total of 359,020 Ordinary Shares of 5p each were granted to Francois Martelet.

 

Director

Position

Number of Options
Granted

Number of Options
Held

Francois Martelet

CEO

359,020

359,020

 

The options have an exercise price of 119.5 pence per share and vest on the 8 June 2018, being the third anniversary of Francois Martelet's appointment as CEO.

 

- Ends -

 

For further information, please contact:

 

Contact Details

 

NetScientific plc

Tel: +44 (0)20 3514 1800

François Martelet, CEO

     

Peter Thoms, CFO




Investec Bank plc (NOMAD & Broker)

Gary Clarence

Daniel Adams

Tel: +44 (0)20 7597 4000


 

Instinctif Partners

Melanie Toyne-Sewell

Jayne Crook

Rosanna Forrest

Tel: +44 (0)20 7457 2020

netscientific@instinctif.com




 

About NetScientific

NetScientific is a transatlantic biomedical and healthcare technology group with a differentiated investment strategy focused solely on digital health, diagnostics and therapeutics. The Group's objective is to source, fund and commercialise companies that significantly improve the lives of people with chronic diseases.

 

For more information, please visit the website at www.netscientific.net. 

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSFSIEFUFISESF